NEWS
Nov
17
, 2017
Nangkuang’s RTU (Ready To Use) Injection Series In
Nangkuang’s RTU (Ready To Use) Injection Series Invited to the Exhibition of the Annual Meeting of Taiwan Neurosurgical Society; All Friends from Industries Are Welcome to Visit Nangkuang’s Booth
Since the launch of Holdipine prefilled syringe Injection IV by Nangkuang’s RTU (Ready to Use) R&D team in August of 2016, the product has received lots of praises and affirmations widely. Currently Holdipine has been widely used by many medical centers and large regional hospitals. To promulgate the importance of RTU products in the application of acute and critical care medicine, Nangkuang is invited to attend the exhibition sponsored by 2017 Annual Meeting of Taiwan Neurosurgical Society. Various featured products, including Holdipine (Nicardipine) Prefilled Syringe Injection and Gipamine (Dopamine) Premixed IV Infusion, will be exhibited. Nangkuang’s RTU team will be available at the booth during the exhibition. All friends from Industries are welcome to visit our booth and give us comments.
During the exhibition, we will focus on the development of RTU products and will present Nangkuang’s featured core techniques -Prefilled Syringe Injection IV and Premix Infusion IV. The clinical benefits of RTU products include：
-Easy to Use- Applicable to various syringes or infusion pumps used for hospital emergency cares
-Quick- Ready to Use. No need for drawing solution and preparation.
-safe- Complete labeling for product recognition. The risks of misuse, needlestick injury, and contamination are reduced.
-Reduced Cost- Labor cost, drug wasting, and managerial risk of medical disputes are reduced.).
Nangkuang’s booth information：
Date ：2017/12/2~3 (Sat & Sun)
Location：5F, Marriott Taipei
No. 199, Lequn 2nd Road, Zhongshan, Taipei
Booth Number： B28
Your visit is welcome. Please contact with our local sales representatives or call 0800-692-929 to make an appointment.
